Pre-registered controlled comparison of auditory function reveals no difference between hospitalised adults with and without COVID-19

Int J Audiol. 2024 May;63(5):300-312. doi: 10.1080/14992027.2023.2213841. Epub 2023 Jun 26.

Abstract

Objective: Several viruses are known to have a negative impact on hearing health. The global prevalence of COVID-19 means that it is crucial to understand whether and how SARS-CoV2 affects hearing. Evidence to date is mixed, with studies frequently exhibiting limitations in the methodological approaches used or the populations sampled, leading to a substantial risk of bias. This study addressed many of these limitations.

Design: A comprehensive battery of measures was administered, including lab-based behavioural and physiological measures, as well as self-report instruments. Performance was thoroughly assessed across the auditory system, including measures of cochlear function, neural function and auditory perception. Hypotheses and analyses were pre-registered.

Study samples: Participants who were hospitalised as a result of COVID-19 (n = 57) were compared with a well-matched control group (n = 40) who had also been hospitalised but had never had COVID-19.

Results: We find no evidence to support the hypothesis that COVID-19 is associated with deficits in auditory function on any auditory test measure. Of all the confirmatory analyses, only the self-report measure of hearing decline indicated any difference between groups.

Conclusion: Results do not support the hypothesis that COVID-19 infection has a significant long-term impact on the auditory system.

Keywords: COVID-19; SARS-Cov2; auditory function; hearing loss.

Publication types

  • Research Support, Non-U.S. Gov't
  • Comparative Study

MeSH terms

  • Adult
  • Aged
  • Auditory Perception
  • COVID-19* / physiopathology
  • Case-Control Studies
  • Female
  • Hearing
  • Hearing Tests / methods
  • Hospitalization*
  • Humans
  • Male
  • Middle Aged
  • SARS-CoV-2